The Europe immunohematology market is projected to grow from USD 750 million in 2025 to approximately USD 1,089.02 million by 2035, registering a CAGR of 3.50%. Growth is driven by rising demand for blood screening, transfusion safety, and advanced diagnostic technologies across healthcare facilities.

Europe Immunohematology Market Statical Scope

Healthcare providers are focusing more on patient safety, operational efficiency, and compliance with regional healthcare standards. The presence of key players such as Grifols, Roche Diagnostics Corporation, and Siemens Healthcare contributes to market growth.

Growing investment in digital healthcare infrastructure and standardized laboratory practices is supporting the use of immunohematology systems. The rising demand for blood transfusion services is also driving the demand for the immunohematology market.

Europe Immunohematology Market Share, By Product, 2025 (%)

• Analyzers - Analyzers hold a significant portion, with a share of 42%, supported by increasing laboratory automation and a strong emphasis on transfusion safety standards. Demand for an efficient, high-throughput diagnostic system supports the growth of the segment.
• Reagents - Reagents dominate the segment, with a share of 58%, driven by rising blood screening requirements and established public healthcare systems. The continuous usage of reagents in routine blood typing, cross-matching, and compatibility testing procedures contributes to the market growth.

Europe Immunohematology Market Share, By Technology, 2025 (%)

• Biochips - Biochips lead the segment, with a share of 33%, driven by growing interest in molecular diagnostics and precision laboratory testing. Healthcare institutions adopt advanced diagnostic platforms offering high precision and multiplex testing capabilities.
• Gel Cards - Gel Cards hold a significant portion, with a share of 24%, because of standardized testing procedures and dependable result interpretation. Blood banks and diagnostic laboratories continue to use gel cards due to their reliability, ease of use, and widespread application in routine immunohematology testing.
• Microplates - Microplates account for a notable share, with a share of 18%, driven by their cost-effectiveness and suitability for high-volume blood screening operations and routine laboratory testing. Diagnostic centres continue utilizing microplate methods to support efficient immunohematology procedures.

Europe Immunohematology Market Share, By End Use, 2025 (%)

• Hospitals - Hospitals lead the segment, with a share of 40%, driven by expanding surgical procedures and strong public healthcare infrastructure. Hospitals are modernizing laboratory operations and adopting automated testing technologies.
• Diagnostic Laboratories - Diagnostic Laboratories hold a significant portion, with a share of 35%, due to growing demand for increasing outsourcing of diagnostic services and high-volume testing capabilities. Increasing blood compatibility testing volumes are encouraging laboratories to adopt advanced immunohematology systems.

Top Companies in the Europe Immunohematology Market

• Grifols S.A.
• Immucor Inc.
• Thermo Fisher Scientific
• Merck KGaA
• Abbott Laboratories

Segments Covered in the Report

By Product

• Analyzers
• Reagents

By Technology

• Biochips
• Gel Cards
• Microplates
• PCR
• Erythrocyte-Magnetized Technology

By End-User

• Hospitals
• Diagnostic Laboratories
• Blood banks